The European Asthma Research and Innovation Partnership (EARIP) aims to reduce asthma deaths in Europe by 25% within ten years and by 50% within 20 years. The partnership, made up of 12 European-based organisations, also aims to halve hospital admission rates, speed up the discovery of new treatments and improve self-management. The EARIP project will do this through identifying key gaps in asthma knowledge; it will then address these using a pioneering and integrated approach to research, development and innovation across Europe. Through rapid dissemination of project results, EARIP will ensure that outcomes from knowledge-based asthma research will quickly result in an improved quality of life for people with asthma.
Recent Posts
- Digital Asthma Self-Management Program for Adults: A Randomized Clinical Trial
- Screening tools for work-related asthma and their diagnostic accuracy: a systematic review
- Impact of natal and childhood metabolic markers on childhood asthma burden – a nationwide cohort study
- External exposome and incident asthma across the life course in 14 European cohorts: a prospective analysis within the EXPANSE project
- Clinical and economic consequences of medication nonadherence: a review of systematic reviews